MD Anderson Cancer Centre, 4D pharma collaborate to evaluate live biotherapeutics in solid tumors
World | News | 0 Comment | 07 Jan, 2019
The University of Texas MD Anderson Cancer Centre and 4D pharma has announced a strategic collaboration to evaluate...Read more
Ironwood Pharma appoints Michael Shetzline as CMO
World | News | 0 Comment | 07 Jan, 2019
Ironwood Pharmaceuticals, Inc. has announced that Michael Shetzline, M.D., Ph.D., will join Ironwood as chief medical of...Read more
Bristol-Myers Squibb to acquire Celgene
World | News | 0 Comment | 04 Jan, 2019
Bristol-Myers Squibb Company and Celgene Corporation has announced that they have entered into a definitive merger agree...Read more
J&J, Locus Bioscience collaborate to develop CRISPR-Cas3 bacteriophage therapeutics
World | News | 0 Comment | 04 Jan, 2019
Locus Biosciences Inc., a biotechnology company developing precision antibacterial therapies, announced today that it ha...Read more
Generex Biotechnology partners with Olaregen Therapeutix
World | News | 0 Comment | 04 Jan, 2019
Generex Biotechnology Corporation has announced that its partially, soon to be fully-owned subsidiary, Olaregen Therapeu...Read more
AstraZeneca’s Bevespi Aerosphere approved in the EU
World | News | 0 Comment | 03 Jan, 2019
AstraZeneca has announced that the European Commission (EC) has approved Bevespi Aerosphere (glycopyrronium/formote...Read more
ImaginAb Announces Strengthening of Board and Executive Leadership Team
World | News | 0 Comment | 03 Jan, 2019
ImaginAb, a clinical stage immuno-oncology imaging company has announced the appointment of Friedhelm Blobel, Ph.D...Read more
Correvio Announces Chief Executive Officer Succession Plan
World | News | 0 Comment | 03 Jan, 2019
Correvio Pharma Corp, a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs h...Read more
USFDA approves Portola Pharmaceuticals’ Andexxa®
World | News | 0 Comment | 03 Jan, 2019
Portola Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s ...Read more
FDA approves Sanofi & MSD’s VAXELIS™
World | News | 0 Comment | 03 Jan, 2019
The U.S. Food and Drug Administration has approved VAXELIS™ (Diphtheria and Tetanus Toxoids and Acellular Pertussi...Read more
AstraZeneca announces phase III trials for roxadustat
World | News | 0 Comment | 03 Jan, 2019
AstraZeneca has announced that the Phase III OLYMPUS and ROCKIES trials for roxadustat each met their primary efficacy e...Read more
AI predicts cancer patients’ symptoms
World | News | 0 Comment | 02 Jan, 2019
Doctors could get a head start treating cancer thanks to new AI developed at the University of Surrey that is able to pr...Read more
Alexion receives early FDA approval For ULTOMIRIS
World | News | 0 Comment | 02 Jan, 2019
Alexion Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved ULTOMIRIS&trad...Read more
PolarityTE registers OsteoTE™ with USFDA
World | News | 0 Comment | 02 Jan, 2019
PolarityTE, Inc., a commercial-stage biotechnology company focused on transforming the lives of patients by discovering,...Read more
George A. Williams to work as 123rd President of the AAO
World | News | 0 Comment | 01 Jan, 2019
George A. Williams, M.D, today begins his term as the 123rd president of the American Academy of Ophthalmology (AAO). Dr...Read more
Ocular Therapeutix Announces Completion of Debt Refinancing
World | News | 0 Comment | 01 Jan, 2019
Ocular Therapeutix, a biopharmaceutical company focused on the formulation, development, and commercialization of innova...Read more
Innovus Pharma announces $3.17 million private placement
World | News | 0 Comment | 01 Jan, 2019
Innovus Pharmaceuticals, an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effectiv...Read more
Nuvo Pharma completes acquisition of Aralez Pharma
World | News | 0 Comment | 01 Jan, 2019
Nuvo Pharmaceuticals Inc. a globally focused, Canadian healthcare company with a portfolio of commercial products today ...Read more